MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 91 filers reported holding MOLECULAR TEMPLATES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $54,000 | -33.3% | 15,680 | -24.1% | 0.00% | – |
| Q4 2021 | $81,000 | -75.1% | 20,646 | -57.4% | 0.00% | – |
| Q3 2021 | $325,000 | -18.5% | 48,422 | -5.2% | 0.00% | -100.0% |
| Q2 2021 | $399,000 | -21.1% | 51,081 | +27.5% | 0.00% | 0.0% |
| Q1 2021 | $506,000 | +34.6% | 40,071 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $376,000 | -14.2% | 40,071 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $438,000 | -13.1% | 40,071 | +9.6% | 0.00% | 0.0% |
| Q2 2020 | $504,000 | +22.9% | 36,551 | +18.4% | 0.00% | 0.0% |
| Q1 2020 | $410,000 | +12.6% | 30,868 | +18.7% | 0.00% | 0.0% |
| Q4 2019 | $364,000 | +110.4% | 26,004 | -0.8% | 0.00% | – |
| Q3 2019 | $173,000 | -21.0% | 26,212 | 0.0% | 0.00% | – |
| Q2 2019 | $219,000 | +97.3% | 26,212 | +37.3% | 0.00% | – |
| Q1 2019 | $111,000 | +44.2% | 19,089 | 0.0% | 0.00% | – |
| Q4 2018 | $77,000 | +2.7% | 19,089 | +38.1% | 0.00% | – |
| Q3 2018 | $75,000 | +4.2% | 13,826 | 0.0% | 0.00% | – |
| Q2 2018 | $72,000 | – | 13,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,052,991 | $1,539,000 | 2.89% |
| Kingsbury Capital Investment Advisors LLC | 298,638 | $224,000 | 0.34% |
| BVF INC/IL | 4,996,565 | $3,746,000 | 0.16% |
| Bellevue Group AG | 11,278,003 | $8,455,000 | 0.12% |
| Frazier Life Sciences Management, L.P. | 1,374,047 | $1,030,000 | 0.08% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 528,104 | $396,000 | 0.05% |
| Abingworth LLP | 200,000 | $150,000 | 0.05% |
| HERBST GROUP, LLC | 10,000 | $7,000 | 0.01% |
| Ergoteles LLC | 159,512 | $120,000 | 0.00% |
| PICTET ASSET MANAGEMENT SA | 2,903,180 | $2,176,000 | 0.00% |